{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:22:21Z","timestamp":1780071741141,"version":"3.54.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T00:00:00Z","timestamp":1570838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00467-019-04350-3","type":"journal-article","created":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T02:02:52Z","timestamp":1570845772000},"page":"2077-2088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists"],"prefix":"10.1007","volume":"35","author":[{"given":"Heidi J.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynna","family":"Van Wyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Selewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-3880","authenticated-orcid":false,"given":"Jennifer G.","family":"Jetton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,12]]},"reference":[{"key":"4350_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jpeds.2012.10.002","volume":"162","author":"DT Selewski","year":"2013","unstructured":"Selewski DT, Jordan BK, Askenazi DJ, Dechert RE, Sarkar S (2013) Acute kidney injury in asphyxiated newborns treated with therapeutic hypothermia. J Pediatr 162:725\u2013729.e721. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2012.10.002","journal-title":"J Pediatr"},{"key":"4350_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/s2352-4642(17)30069-x","volume":"1","author":"JG Jetton","year":"2017","unstructured":"Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, Chishti AS, Woroniecki R, Mammen C, Swanson JR, Sridhar S, Wong CS, Kupferman JC, Griffin RL, Askenazi DJ (2017) Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 1:184\u2013194. \nhttps:\/\/doi.org\/10.1016\/s2352-4642(17)30069-x","journal-title":"Lancet Child Adolesc Health"},{"key":"4350_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00467-017-3809-y","volume":"33","author":"CN Criss","year":"2018","unstructured":"Criss CN, Selewski DT, Sunkara B, Gish JS, Hsieh L, McLeod JS, Robertson JO, Matusko N, Gadepalli SK (2018) Acute kidney injury in necrotizing enterocolitis predicts mortality. Pediatr Nephrol 33:503\u2013510. \nhttps:\/\/doi.org\/10.1007\/s00467-017-3809-y","journal-title":"Pediatr Nephrol"},{"key":"4350_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jpedsurg.2010.11.031","volume":"46","author":"SK Gadepalli","year":"2011","unstructured":"Gadepalli SK, Selewski DT, Drongowski RA, Mychaliska GB (2011) Acute kidney injury in congenital diaphragmatic hernia requiring extracorporeal life support: an insidious problem. J Pediatr Surg 46:630\u2013635. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2010.11.031","journal-title":"J Pediatr Surg"},{"key":"4350_CR5","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2215\/cjn.05190514","volume":"9","author":"JB Carmody","year":"2014","unstructured":"Carmody JB, Swanson JR, Rhone ET, Charlton JR (2014) Recognition and reporting of AKI in very low birth weight infants. Clin J Am Soc Nephrol 9:2036\u20132043. \nhttps:\/\/doi.org\/10.2215\/cjn.05190514","journal-title":"Clin J Am Soc Nephrol"},{"key":"4350_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3109\/14767058.2013.860522","volume":"27","author":"ET Rhone","year":"2014","unstructured":"Rhone ET, Carmody JB, Swanson JR, Charlton JR (2014) Nephrotoxic medication exposure in very low birth weight infants. J Matern Fetal Neonatal Med 27:1485\u20131490. \nhttps:\/\/doi.org\/10.3109\/14767058.2013.860522","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4350_CR7","first-page":"1070","volume":"4","author":"M Barhight","year":"2017","unstructured":"Barhight M, Altaye M, Gist KM, Isemann B, Goldstein SL, Akinbi H (2017) Nephrotoxic medications and associated acute kidney injury in very low birth weight infants. J Clin Nephrol Res 4:1070","journal-title":"J Clin Nephrol Res"},{"key":"4350_CR8","doi-asserted-by":"publisher","unstructured":"Greenhow TL, Hung YY, Pantell RH (2016) Management and outcomes of previously healthy, full-term, febrile infants ages 7 to 90 days. Pediatrics 138(6). \nhttps:\/\/doi.org\/10.1542\/peds.2016-0270","DOI":"10.1542\/peds.2016-0270"},{"key":"4350_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.annemergmed.2017.07.488","volume":"71","author":"EC Powell","year":"2018","unstructured":"Powell EC, Mahajan PV, Roosevelt G, Hoyle JD Jr, Gattu R, Cruz AT, Rogers AJ, Atabaki SM, Jaffe DM, Casper TC, Ramilo O, Kuppermann N (2018) Epidemiology of bacteremia in febrile infants aged 60 days and younger. Ann Emerg Med 71:211\u2013216. \nhttps:\/\/doi.org\/10.1016\/j.annemergmed.2017.07.488","journal-title":"Ann Emerg Med"},{"key":"4350_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1055\/s-0033-1361933","volume":"31","author":"EM Hsieh","year":"2014","unstructured":"Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB (2014) Medication use in the neonatal intensive care unit. Am J Perinatol 31:811\u2013821. \nhttps:\/\/doi.org\/10.1055\/s-0033-1361933","journal-title":"Am J Perinatol"},{"key":"4350_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14787210.2014.878648","volume":"12","author":"A Kent","year":"2014","unstructured":"Kent A, Turner MA, Sharland M, Heath PT (2014) Aminoglycoside toxicity in neonates: something to worry about? Exper Rev Anti Infect Ther 12:319\u2013331","journal-title":"Exper Rev Anti Infect Ther"},{"key":"4350_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/pec.0000000000000400","volume":"31","author":"JB Cantey","year":"2015","unstructured":"Cantey JB, Lopez-Medina E, Nguyen S, Doern C, Garcia C (2015) Empiric antibiotics for serious bacterial infection in young infants: opportunities for stewardship. Pediatr Emerg Care 31:568\u2013571. \nhttps:\/\/doi.org\/10.1097\/pec.0000000000000400","journal-title":"Pediatr Emerg Care"},{"key":"4350_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","volume":"15","author":"AK Sullins","year":"2013","unstructured":"Sullins AK, Abdel-Rahman SM (2013) Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. Paediatr Drugs 15:93\u2013117. \nhttps:\/\/doi.org\/10.1007\/s40272-013-0017-5","journal-title":"Paediatr Drugs"},{"key":"4350_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1542\/peds.2005-0179","volume":"117","author":"RH Clark","year":"2006","unstructured":"Clark RH, Bloom BT, Spitzer AR, Gerstmann DR (2006) Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 117:67\u201374. \nhttps:\/\/doi.org\/10.1542\/peds.2005-0179","journal-title":"Pediatrics"},{"key":"4350_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1542\/peds.2011-1466","volume":"128","author":"CJ Baker","year":"2011","unstructured":"Baker CJ, Byington CL, Polin RA (2011) Policy statement\u2014recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 128:611\u2013616. \nhttps:\/\/doi.org\/10.1542\/peds.2011-1466","journal-title":"Pediatrics"},{"key":"4350_CR16","unstructured":"Pocket book of hospital care for children: guidelines for the management of common childhood illnesses (2013). Geneva, Switzerland"},{"key":"4350_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jpeds.2008.02.031","volume":"153","author":"AC Caviness","year":"2008","unstructured":"Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ (2008) The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 153:164\u2013169. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2008.02.031","journal-title":"J Pediatr"},{"key":"4350_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/mop.0000000000000311","volume":"28","author":"MH Hanna","year":"2016","unstructured":"Hanna MH, Askenazi DJ, Selewski DT (2016) Drug-induced acute kidney injury in neonates. Curr Opin Pediatr 28:180\u2013187. \nhttps:\/\/doi.org\/10.1097\/mop.0000000000000311","journal-title":"Curr Opin Pediatr"},{"key":"4350_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N (2010) Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 86:329\u2013338. \nhttps:\/\/doi.org\/10.1016\/j.earlhumdev.2010.05.010","journal-title":"Early Hum Dev"},{"key":"4350_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD (2015) Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr 169:397\u2013403. \nhttps:\/\/doi.org\/10.1001\/jamapediatrics.2014.3269","journal-title":"JAMA Pediatr"},{"key":"4350_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s0140-6736(05)17946-x","volume":"365","author":"PD Gluckman","year":"2005","unstructured":"Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ (2005) Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365:663\u2013670. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(05)17946-x","journal-title":"Lancet"},{"key":"4350_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH (2005) Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353:1574\u20131584. \nhttps:\/\/doi.org\/10.1056\/NEJMcps050929","journal-title":"N Engl J Med"},{"key":"4350_CR23","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","volume":"366","author":"S Shankaran","year":"2012","unstructured":"Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, Gustafson KE, Leach TM, Green C, Bara R, Petrie Huitema CM, Ehrenkranz RA, Tyson JE, Das A, Hammond J, Peralta-Carcelen M, Evans PW, Heyne RJ, Wilson-Costello DE, Vaucher YE, Bauer CR, Dusick AM, Adams-Chapman I, Goldstein RF, Guillet R, Papile LA, Higgins RD (2012) Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 366:2085\u20132092. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1112066","journal-title":"N Engl J Med"},{"key":"4350_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fped.2017.00016","volume":"5","author":"DA LaRosa","year":"2017","unstructured":"LaRosa DA, Ellery SJ, Walker DW, Dickinson H (2017) Understanding the full spectrum of organ injury following intrapartum asphyxia. Front Pediatr 5:16. \nhttps:\/\/doi.org\/10.3389\/fped.2017.00016","journal-title":"Front Pediatr"},{"key":"4350_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/pr.2013.230","volume":"75","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Askenazi DJ, Jordan BK, Bhagat I, Bapuraj JR, Dechert RE, Selewski DT (2014) Relationship between acute kidney injury and brain MRI findings in asphyxiated newborns after therapeutic hypothermia. Pediatr Res 75:431\u2013435. \nhttps:\/\/doi.org\/10.1038\/pr.2013.230","journal-title":"Pediatr Res"},{"key":"4350_CR26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.4.e45","volume":"105","author":"AG Jenik","year":"2000","unstructured":"Jenik AG, Ceriani Cernadas JM, Gorenstein A, Ramirez JA, Vain N, Armadans M, Ferraris JR (2000) A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 105:E45","journal-title":"Pediatrics"},{"key":"4350_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00467-005-1980-z","volume":"20","author":"AF Bakr","year":"2005","unstructured":"Bakr AF (2005) Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia\u2014a study in a developing country. Pediatr Nephrol 20:1249\u20131252. \nhttps:\/\/doi.org\/10.1007\/s00467-005-1980-z","journal-title":"Pediatr Nephrol"},{"key":"4350_CR28","first-page":"222","volume":"3","author":"Z Eslami","year":"2009","unstructured":"Eslami Z, Shajari A, Kheirandish M, Heidary A (2009) Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia. Iran J Kidney Dis 3:222\u2013226","journal-title":"Iran J Kidney Dis"},{"key":"4350_CR29","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1111\/apa.13469","volume":"105","author":"A Raina","year":"2016","unstructured":"Raina A, Pandita A, Harish R, Yachha M, Jamwal A (2016) Treating perinatal asphyxia with theophylline at birth helps to reduce the severity of renal dysfunction in term neonates. Acta Paediatr 105:e448\u2013e451. \nhttps:\/\/doi.org\/10.1111\/apa.13469","journal-title":"Acta Paediatr"},{"key":"4350_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/jp.2009.37","volume":"29","author":"S Sarkar","year":"2009","unstructured":"Sarkar S, Barks JD, Bhagat I, Donn SM (2009) Effects of therapeutic hypothermia on multiorgan dysfunction in asphyxiated newborns: whole-body cooling versus selective head cooling. J Perinatol 29:558\u2013563. \nhttps:\/\/doi.org\/10.1038\/jp.2009.37","journal-title":"J Perinatol"},{"key":"4350_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/S0270-9295(03)00130-X","volume":"23","author":"P Saikumar","year":"2003","unstructured":"Saikumar P, Venkatachalam MA (2003) Role of apoptosis in hypoxic\/ischemic damage in the kidney. Semin Nephrol 23:511\u2013521","journal-title":"Semin Nephrol"},{"key":"4350_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4314\/ahs.v14i3.26","volume":"14","author":"D Alaro","year":"2014","unstructured":"Alaro D, Bashir A, Musoke R, Wanaiana L (2014) Prevalence and outcomes of acute kidney injury in term neonates with perinatal asphyxia. Afr Health Sci 14:682\u2013688. \nhttps:\/\/doi.org\/10.4314\/ahs.v14i3.26","journal-title":"Afr Health Sci"},{"key":"4350_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00467-018-4068-2","volume":"34","author":"MJ Kirkley","year":"2019","unstructured":"Kirkley MJ, Boohaker L, Griffin R, Soranno DE, Gien J, Askenazi D, Gist KM (2019) Acute kidney injury in neonatal encephalopathy: an evaluation of the AWAKEN database. Pediatr Nephrol 34:169\u2013176. \nhttps:\/\/doi.org\/10.1007\/s00467-018-4068-2","journal-title":"Pediatr Nephrol"},{"key":"4350_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/14767058.2013.818646","volume":"27","author":"E Hadzimuratovic","year":"2014","unstructured":"Hadzimuratovic E, Skrablin S, Hadzimuratovic A, Dinarevic SM (2014) Postasphyxial renal injury in newborns as a prognostic factor of neurological outcome. J Matern Fetal Neonatal Med 27:407\u2013410. \nhttps:\/\/doi.org\/10.3109\/14767058.2013.818646","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4350_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jcpt.12711","volume":"43","author":"DW Choi","year":"2018","unstructured":"Choi DW, Park JH, Lee SY, An SH (2018) Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: a systematic review and meta-analysis. J Clin Pharm Ther 43:484\u2013492. \nhttps:\/\/doi.org\/10.1111\/jcpt.12711","journal-title":"J Clin Pharm Ther"},{"key":"4350_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/bcp.12883","volume":"81","author":"YA Bijleveld","year":"2016","unstructured":"Bijleveld YA, de Haan TR, van der Lee HJ, Groenendaal F, Dijk PH, van Heijst A, de Jonge RC, Dijkman KP, van Straaten HL, Rijken M, Zonnenberg IA, Cools F, Zecic A, Nuytemans DH, van Kaam AH, Mathot RA (2016) Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia. Br J Clin Pharmacol 81:1067\u20131077. \nhttps:\/\/doi.org\/10.1111\/bcp.12883","journal-title":"Br J Clin Pharmacol"},{"key":"4350_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12098-014-1527-z","volume":"82","author":"JY Ting","year":"2015","unstructured":"Ting JY, Kwan E, McDougal A, Osiovich H (2015) Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Indian J Pediatr 82:119\u2013125. \nhttps:\/\/doi.org\/10.1007\/s12098-014-1527-z","journal-title":"Indian J Pediatr"},{"key":"4350_CR38","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/phar.2186","volume":"38","author":"JJ Cies","year":"2018","unstructured":"Cies JJ, Habib T, Bains V, Young M, Menkiti OR (2018) Population pharmacokinetics of gentamicin in neonates with hypoxemic-ischemic encephalopathy receiving controlled hypothermia. Pharmacotherapy 38:1120\u20131129. \nhttps:\/\/doi.org\/10.1002\/phar.2186","journal-title":"Pharmacotherapy"},{"key":"4350_CR39","doi-asserted-by":"publisher","first-page":"Cd005091","DOI":"10.1002\/14651858.CD005091.pub4","volume":"12","author":"SC Rao","year":"2016","unstructured":"Rao SC, Srinivasjois R, Moon K (2016) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 12:Cd005091. \nhttps:\/\/doi.org\/10.1002\/14651858.CD005091.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"4350_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/phar.1263","volume":"33","author":"A Frymoyer","year":"2013","unstructured":"Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ (2013) Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy 33:718\u2013726. \nhttps:\/\/doi.org\/10.1002\/phar.1263","journal-title":"Pharmacotherapy"},{"key":"4350_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpeds.2018.04.076","volume":"200","author":"VY Chock","year":"2018","unstructured":"Chock VY, Frymoyer A, Yeh CG, Van Meurs KP (2018) Renal saturation and acute kidney injury in neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Pediatr 200:232\u2013239.e231. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2018.04.076","journal-title":"J Pediatr"},{"key":"4350_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00431-012-1890-6","volume":"172","author":"DU Sweetman","year":"2013","unstructured":"Sweetman DU, Molloy EJ (2013) Biomarkers of acute kidney injury in neonatal encephalopathy. Eur J Pediatr 172:305\u2013316. \nhttps:\/\/doi.org\/10.1007\/s00431-012-1890-6","journal-title":"Eur J Pediatr"},{"key":"4350_CR43","unstructured":"Benitz W (2015) Patent ductus arteriosus. Fanaroff and Martin\u2019s neonatal-perinatal medicine, vol 10th. Elsevier Saunders, Philadelphia, PA"},{"key":"4350_CR44","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1542\/neo.9-10-e477","volume":"9","author":"J Gien","year":"2008","unstructured":"Gien J (2008) Controversies in the management of patent ductus arteriosus. NeoReviews 9:e477\u2013e482. \nhttps:\/\/doi.org\/10.1542\/neo.9-10-e477","journal-title":"NeoReviews"},{"key":"4350_CR45","doi-asserted-by":"publisher","unstructured":"Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (7):Cd000174. \nhttps:\/\/doi.org\/10.1002\/14651858.CD000174.pub2","DOI":"10.1002\/14651858.CD000174.pub2"},{"key":"4350_CR46","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00431-016-2705-y","volume":"175","author":"JL Slaughter","year":"2016","unstructured":"Slaughter JL, Reagan PB, Bapat RV, Newman TB, Klebanoff MA (2016) Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children\u2019s hospitals. Eur J Pediatr 175:775\u2013783. \nhttps:\/\/doi.org\/10.1007\/s00431-016-2705-y","journal-title":"Eur J Pediatr"},{"key":"4350_CR47","doi-asserted-by":"publisher","first-page":"13s","DOI":"10.1016\/S0002-9343(99)00113-8","volume":"106","author":"A Whelton","year":"1999","unstructured":"Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106:13s\u201324s","journal-title":"Am J Med"},{"key":"4350_CR48","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/nejm200106283442602","volume":"344","author":"B Schmidt","year":"2001","unstructured":"Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL (2001) Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344:1966\u20131972. \nhttps:\/\/doi.org\/10.1056\/nejm200106283442602","journal-title":"N Engl J Med"},{"key":"4350_CR49","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00467-003-1402-z","volume":"19","author":"S Akima","year":"2004","unstructured":"Akima S, Kent A, Reynolds GJ, Gallagher M, Falk MC (2004) Indomethacin and renal impairment in neonates. Pediatr Nephrol 19:490\u2013493. \nhttps:\/\/doi.org\/10.1007\/s00467-003-1402-z","journal-title":"Pediatr Nephrol"},{"key":"4350_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/jp.2017.80","volume":"37","author":"JE Constance","year":"2017","unstructured":"Constance JE, Reith D, Ward RM, Balch A, Stockmann C, Korgenski EK, Thorell EA, Sherwin CMT (2017) Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. J Perinatol 37:1093\u20131102. \nhttps:\/\/doi.org\/10.1038\/jp.2017.80","journal-title":"J Perinatol"},{"key":"4350_CR51","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00467-019-4194-5","volume":"34","author":"B Majed","year":"2019","unstructured":"Majed B, Bateman DA, Uy N, Lin F (2019) Patent ductus arteriosus is associated with acute kidney injury in the preterm infant. Pediatr Nephrol 34:1129\u20131139. \nhttps:\/\/doi.org\/10.1007\/s00467-019-4194-5","journal-title":"Pediatr Nephrol"},{"key":"4350_CR52","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jpeds.2015.09.028","volume":"167","author":"A El-Khuffash","year":"2015","unstructured":"El-Khuffash A, James AT, Corcoran JD, Dicker P, Franklin O, Elsayed YN, Ting JY, Sehgal A, Malikiwi A, Harabor A, Soraisham AS, McNamara PJ (2015) A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 167:1354\u20131361.e1352. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2015.09.028","journal-title":"J Pediatr"},{"key":"4350_CR53","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/ped.12915","volume":"58","author":"TB Polat","year":"2016","unstructured":"Polat TB, Celik IH, Erdeve O (2016) Early predictive echocardiographic features of hemodynamically significant patent ductus arteriosus in preterm VLBW infants. Pediatr Int 58:589\u2013594. \nhttps:\/\/doi.org\/10.1111\/ped.12915","journal-title":"Pediatr Int"},{"key":"4350_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","volume":"205","author":"RI Clyman","year":"2019","unstructured":"Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, Lindqvist J, Farooqi A, Katheria A, Sauberan J, Singh J, Nelson K, Wickremasinghe A, Dong L, Hassinger DC, Aucott SW, Hayashi M, Heuchan AM, Carey WA, Derrick M, Fernandez E, Sankar M, Leone T, Perez J, Serize A (2019) PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr 205:41\u201348.e46. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2018.09.012","journal-title":"J Pediatr"},{"key":"4350_CR55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0022-3476(83)80022-5","volume":"102","author":"WM Gersony","year":"1983","unstructured":"Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS (1983) Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 102:895\u2013906","journal-title":"J Pediatr"},{"key":"4350_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","volume":"176","author":"AE El-Mashad","year":"2017","unstructured":"El-Mashad AE, El-Mahdy H, El Amrousy D, Elgendy M (2017) Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 176:233\u2013240. \nhttps:\/\/doi.org\/10.1007\/s00431-016-2830-7","journal-title":"Eur J Pediatr"},{"key":"4350_CR57","doi-asserted-by":"publisher","first-page":"Cd010061","DOI":"10.1002\/14651858.CD010061.pub3","volume":"4","author":"A Ohlsson","year":"2018","unstructured":"Ohlsson A, Shah PS (2018) Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 4:Cd010061. \nhttps:\/\/doi.org\/10.1002\/14651858.CD010061.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"4350_CR58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5863\/1551-6776-12.3.194","volume":"12","author":"B Van Overmeire","year":"2007","unstructured":"Van Overmeire B (2007) Common clinical and practical questions on the use of intravenous ibuprofen lysine for the treatment of patent ductus arteriosus. J Pediatr Pharmacol Ther 12:194\u2013206. \nhttps:\/\/doi.org\/10.5863\/1551-6776-12.3.194","journal-title":"J Pediatr Pharmacol Ther"},{"key":"4350_CR59","doi-asserted-by":"publisher","first-page":"Cd003481","DOI":"10.1002\/14651858.CD003481.pub7","volume":"9","author":"A Ohlsson","year":"2018","unstructured":"Ohlsson A, Walia R, Shah SS (2018) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 9:Cd003481. \nhttps:\/\/doi.org\/10.1002\/14651858.CD003481.pub7","journal-title":"Cochrane Database Syst Rev"},{"key":"4350_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1067\/mpd.2001.110528","volume":"138","author":"B Van Overmeire","year":"2001","unstructured":"Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P (2001) Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 138:205\u2013211. \nhttps:\/\/doi.org\/10.1067\/mpd.2001.110528","journal-title":"J Pediatr"},{"key":"4350_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jp.7211895","volume":"28","author":"BE Stephens","year":"2008","unstructured":"Stephens BE, Gargus RA, Walden RV, Mance M, Nye J, McKinley L, Tucker R, Vohr BR (2008) Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants. J Perinatol 28:123\u2013128. \nhttps:\/\/doi.org\/10.1038\/sj.jp.7211895","journal-title":"J Perinatol"},{"key":"4350_CR62","doi-asserted-by":"publisher","unstructured":"Barrington K, Brion LP (2002) Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database Syst Rev (3):Cd003213. \nhttps:\/\/doi.org\/10.1002\/14651858.Cd003213","DOI":"10.1002\/14651858.Cd003213"},{"key":"4350_CR63","doi-asserted-by":"publisher","unstructured":"Brion LP, Campbell DE (2001) Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants. Cochrane Database Syst Rev (3):Cd001148. \nhttps:\/\/doi.org\/10.1002\/14651858.Cd001148","DOI":"10.1002\/14651858.Cd001148"},{"key":"4350_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2249-4847.92228","volume":"1","author":"JA Anabrees","year":"2012","unstructured":"Anabrees JA, Aifaleh KM (2012) Fluid restriction and prophylactic indomethacin in extremely low birth weight infants. J Clin Neonatol 1:1\u20135. \nhttps:\/\/doi.org\/10.4103\/2249-4847.92228","journal-title":"J Clin Neonatol"},{"key":"4350_CR65","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3730","volume":"137","author":"WE Benitz","year":"2016","unstructured":"Benitz WE (2016) Patent ductus arteriosus in preterm infants. Pediatrics 137:e20153730. \nhttps:\/\/doi.org\/10.1542\/peds.2015-3730","journal-title":"Pediatrics"},{"key":"4350_CR66","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jamcollsurg.2013.11.015","volume":"218","author":"MA Hull","year":"2014","unstructured":"Hull MA, Fisher JG, Gutierrez IM, Jones BA, Kang KH, Kenny M, Zurakowski D, Modi BP, Horbar JD, Jaksic T (2014) Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study. J Am Coll Surg 218:1148\u20131155. \nhttps:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.11.015","journal-title":"J Am Coll Surg"},{"key":"4350_CR67","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.jpedsurg.2015.07.009","volume":"50","author":"FH Heida","year":"2015","unstructured":"Heida FH, Hulscher JB, Schurink M, van Vliet MJ, Kooi EM, Kasper DC, Pones M, Bos AF, Benkoe TM (2015) Bloodstream infections during the onset of necrotizing enterocolitis and their relation with the pro-inflammatory response, gut wall integrity and severity of disease in NEC. J Pediatr Surg 50:1837\u20131841. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2015.07.009","journal-title":"J Pediatr Surg"},{"key":"4350_CR68","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/s0140-6736(06)69525-1","volume":"368","author":"PW Lin","year":"2006","unstructured":"Lin PW, Stoll BJ (2006) Necrotising enterocolitis. Lancet 368:1271\u20131283. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(06)69525-1","journal-title":"Lancet"},{"key":"4350_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133\u2013164. \nhttps:\/\/doi.org\/10.1086\/649554","journal-title":"Clin Infect Dis"},{"key":"4350_CR70","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jpeds.2010.08.019","volume":"158","author":"S McKamy","year":"2011","unstructured":"McKamy S, Hernandez E, Jahng M, Moriwaki T, Deveikis A, Le J (2011) Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr 158:422\u2013426. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2010.08.019","journal-title":"J Pediatr"},{"key":"4350_CR71","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ijantimicag.2018.08.001","volume":"52","author":"J Carreno","year":"2018","unstructured":"Carreno J, Smiraglia T, Hunter C, Tobin E, Lomaestro B (2018) Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin\/tazobactam in combination or as monotherapy. Int J Antimicrob Agents 52:643\u2013650. \nhttps:\/\/doi.org\/10.1016\/j.ijantimicag.2018.08.001","journal-title":"Int J Antimicrob Agents"},{"key":"4350_CR72","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.3219","volume":"171","author":"KJ Downes","year":"2017","unstructured":"Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE (2017) Association of acute kidney injury with concomitant vancomycin and piperacillin\/tazobactam treatment among hospitalized children. JAMA Pediatr 171:e173219. \nhttps:\/\/doi.org\/10.1001\/jamapediatrics.2017.3219","journal-title":"JAMA Pediatr"},{"key":"4350_CR73","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.diagmicrobio.2014.02.003","volume":"79","author":"NA Maldonado","year":"2014","unstructured":"Maldonado NA, Cano LE, De Bedout C, Arbelaez CA, Roncancio G, Tabares AM, Robledo CG, Robledo J (2014) Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellin, Colombia 2010-2011. Diagn Microbiol Infect Dis 79:280\u2013286. \nhttps:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.02.003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4350_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00006454-199001000-00012","volume":"9","author":"KM Butler","year":"1990","unstructured":"Butler KM, Rench MA, Baker CJ (1990) Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 9:51\u201356. \nhttps:\/\/doi.org\/10.1097\/00006454-199001000-00012","journal-title":"Pediatr Infect Dis J"},{"key":"4350_CR75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/inf.0000000000001913","volume":"37","author":"J Autmizguine","year":"2018","unstructured":"Autmizguine J, Tan S, Cohen-Wolkowiez M, Cotten CM, Wiederhold N, Goldberg RN, Adams-Chapman I, Stoll BJ, Smith PB, Benjamin DK Jr (2018) Antifungal susceptibility and clinical outcome in neonatal candidiasis. Pediatr Infect Dis J 37:923\u2013929. \nhttps:\/\/doi.org\/10.1097\/inf.0000000000001913","journal-title":"Pediatr Infect Dis J"},{"key":"4350_CR76","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11096-012-9654-y","volume":"34","author":"E Horwitz","year":"2012","unstructured":"Horwitz E, Shavit O, Shouval R, Hoffman A, Shapiro M, Moses AE (2012) Evaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactions. Int J Clin Pharm 34:611\u2013617. \nhttps:\/\/doi.org\/10.1007\/s11096-012-9654-y","journal-title":"Int J Clin Pharm"},{"key":"4350_CR77","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:409\u2013417. \nhttps:\/\/doi.org\/10.1093\/cid\/civ1194","journal-title":"Clin Infect Dis"},{"key":"4350_CR78","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/INF.0b013e3182467a72","volume":"31","author":"SB Ascher","year":"2012","unstructured":"Ascher SB, Smith PB, Watt K, Benjamin DK, Cohen-Wolkowiez M, Clark RH, Benjamin DK Jr, Moran C (2012) Antifungal therapy and outcomes in infants with invasive Candida infections. Pediatr Infect Dis J 31:439\u2013443. \nhttps:\/\/doi.org\/10.1097\/INF.0b013e3182467a72","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"4350_CR79","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/s0378-3782(12)70024-5","volume":"88","author":"P Manzoni","year":"2012","unstructured":"Manzoni P, Galletto P, Rizzollo S, Franco C, Gallo E, Antonucci R, Fanos V, Farina D (2012) Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates. Early Hum Dev 88(Suppl 2):S86\u2013S91. \nhttps:\/\/doi.org\/10.1016\/s0378-3782(12)70024-5","journal-title":"Early Hum Dev"},{"key":"4350_CR80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.earlhumdev.2012.07.015","volume":"89","author":"E Karadag-Oncel","year":"2013","unstructured":"Karadag-Oncel E, Ozsurekci Y, Yurdakok M, Kara A (2013) Is liposomal amphotericin B really safety in neonates? Early Hum Dev 89:35\u201336. \nhttps:\/\/doi.org\/10.1016\/j.earlhumdev.2012.07.015","journal-title":"Early Hum Dev"},{"key":"4350_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/00006454-199802000-00013","volume":"17","author":"A Scarcella","year":"1998","unstructured":"Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A (1998) Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J 17:146\u2013148","journal-title":"Pediatr Infect Dis J"},{"key":"4350_CR82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jphp.12878","volume":"70","author":"C Silver","year":"2018","unstructured":"Silver C, Rostas S (2018) Comprehensive drug utilization review in neonates: liposomal amphotericin B. J Pharm Pharmacol 70:328\u2013334. \nhttps:\/\/doi.org\/10.1111\/jphp.12878","journal-title":"J Pharm Pharmacol"},{"key":"4350_CR83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00043426-200407000-00004","volume":"26","author":"RD Goldman","year":"2004","unstructured":"Goldman RD, Koren G (2004) Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol 26:421\u2013426","journal-title":"J Pediatr Hematol Oncol"},{"key":"4350_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpeds.2016.01.051","volume":"172","author":"JB Carmody","year":"2016","unstructured":"Carmody JB, Harer MW, Denotti AR, Swanson JR, Charlton JR (2016) Caffeine exposure and risk of acute kidney injury in a retrospective cohort of very low birth weight neonates. J Pediatr 172:63\u201368.e61. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2016.01.051","journal-title":"J Pediatr"},{"key":"4350_CR85","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0322","volume":"172","author":"MW Harer","year":"2018","unstructured":"Harer MW, Askenazi DJ, Boohaker LJ, Carmody JB, Griffin RL, Guillet R, Selewski DT, Swanson JR, Charlton JR (2018) Association between early caffeine citrate administration and risk of acute kidney injury in preterm neonates: results from the AWAKEN study. JAMA Pediatr 172:e180322. \nhttps:\/\/doi.org\/10.1001\/jamapediatrics.2018.0322","journal-title":"JAMA Pediatr"},{"key":"4350_CR86","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpeds.2006.03.053","volume":"149","author":"MA Bhat","year":"2006","unstructured":"Bhat MA, Shah ZA, Makhdoomi MS, Mufti MH (2006) Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr 149:180\u2013184. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2006.03.053","journal-title":"J Pediatr"},{"key":"4350_CR87","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/jp.2012.97","volume":"33","author":"H Al-Wassia","year":"2013","unstructured":"Al-Wassia H, Alshaikh B, Sauve R (2013) Prophylactic theophylline for the prevention of severe renal dysfunction in term and post-term neonates with perinatal asphyxia: a systematic review and meta-analysis of randomized controlled trials. J Perinatol 33:271\u2013277. \nhttps:\/\/doi.org\/10.1038\/jp.2012.97","journal-title":"J Perinatol"},{"key":"4350_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"key":"4350_CR89","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s10157-019-01706-9","volume":"23","author":"I Bellos","year":"2019","unstructured":"Bellos I, Iliopoulos DC, Perrea DN (2019) Pharmacological interventions for the prevention of acute kidney injury after pediatric cardiac surgery: a network meta-analysis. Clin Exp Nephrol 23:782\u2013791. \nhttps:\/\/doi.org\/10.1007\/s10157-019-01706-9","journal-title":"Clin Exp Nephrol"},{"key":"4350_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0037-1604260","volume":"35","author":"AL Kent","year":"2018","unstructured":"Kent AL, Charlton JR, Guillet R, Gist KM, Hanna M, El Samra A, Fletcher J, Selewski DT, Mammen C (2018) Neonatal acute kidney injury: a survey of neonatologists\u2019 and nephrologists\u2019 perceptions and practice management. Am J Perinatol 35:1\u20139. \nhttps:\/\/doi.org\/10.1055\/s-0037-1604260","journal-title":"Am J Perinatol"},{"key":"4350_CR91","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1542\/peds.2013-0794","volume":"132","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, Seid M, Ashby M, Foertmeyer N, Brunner L, Lesko A, Barclay C, Lannon C, Muething S (2013) Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132:e756\u2013e767. \nhttps:\/\/doi.org\/10.1542\/peds.2013-0794","journal-title":"Pediatrics"},{"key":"4350_CR92","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2215\/cjn.01250119","volume":"14","author":"K Kashani","year":"2019","unstructured":"Kashani K, Rosner MH, Haase M, Lewington AJP, O\u2019Donoghue DJ, Wilson FP, Nadim MK, Silver SA, Zarbock A, Ostermann M, Mehta RL, Kane-Gill SL, Ding X, Pickkers P, Bihorac A, Siew ED, Barreto EF, Macedo E, Kellum JA, Palevsky PM, Tolwani AJ, Ronco C, Juncos LA, Rewa OG, Bagshaw SM, Mottes TA, Koyner JL, Liu KD, Forni LG, Heung M, Wu VC (2019) Quality improvement goals for acute kidney injury. Clin J Am Soc Nephrol 14:941\u2013953. \nhttps:\/\/doi.org\/10.2215\/cjn.01250119","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04350-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T23:40:22Z","timestamp":1602373222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,12]]},"references-count":92,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04350-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,12]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}